ArticleTranslational lung cancer research2024

Pros and cons of subcutaneous (SC) versus intravenous (IV) administration of immune checkpoint inhibitors in non-small cell lung cancer.

Julie Moeller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.